What is the global market size of Biologics Safety Testing Market?

Global Biologics Safety Testing Market size was valued at USD 4.2 billion in 2021 and is poised to grow from USD 4.7 billion in 2022 to USD 11.47 billion by 2030, growing at a CAGR of 11.8% in the forecast period (2023-2030).

Who are the key vendors in the Global Biologics Safety Testing Market?

The Global Biologics Safety Testing Market showcases a competitive landscape characterised by a diverse mix of well-established brands, emerging players, and specialised producers. In this dynamic environment, innovation serves as a pivotal competitive edge. Leading brands dedicate significant resources to research and development endeavours, consistently introducing fresh flavours, innovative packaging formats, and health-focused variations in response to ever-evolving consumer preferences. 'Cytovance Biologics ', 'Eurofins Scientific ', 'Merck KGaA ', 'Biomerieux SA ', 'Lonza', 'Promega Corporation ', 'Thermo Fisher Scientific ', 'WuXi AppTec ', 'Nelson Laboratories, LLC ', 'Almac Group ', 'GenScript ', 'InvivoGen ', 'Toxikon ', 'Maravai LifeSciences'

What is the key driver of Global Biologics Safety Testing Market?

The expansions witnessed in the pharmaceutical and biotechnology sectors, propelled by substantial investments in research and development, signify a pivotal epoch in healthcare progress. These industries stand at the forefront of creating pharmaceuticals, biologics, and vaccines, actively addressing the complexities associated with diverse healthcare challenges, especially in combating intricate diseases. This surge in innovation inevitably leads to an increased necessity for stringent safety evaluations, wherein biological safety testing plays a pivotal role in safeguarding patient well-being.

What is the key market trend for Global Biologics Safety Testing Market?

Global regulatory bodies have embarked on a path of heightened vigilance over biopharmaceutical products, prioritising both patient safety and product quality. These stringent regulations mandate an exhaustive spectrum of safety evaluations, elevating biological safety testing to a cornerstone in the landscape of drug approvals. For pharmaceutical and biotech enterprises, strict adherence to these evolving standards isn't just a necessity but a crucial pathway to securing product approval and market entry. This escalating emphasis on compliance fuels an increased demand for testing services, firmly cementing the pivotal role of biological safety testing within this framework.

Which region accounted for the largest share in Biologics Safety Testing Market?

North America emerges as the leader in shaping and propelling the market dynamics, poised to sustain its influential trajectory in the forecast period. This regional dominance is attributed to various key factors, notably the robust presence of a multitude of biotechnology and pharmaceutical companies. Renowned for its status as an innovation hub, North America consistently fosters the evolution of cutting-edge technologies, driving advancements and breakthroughs within the industry.

Global Biological Safety Testing Companies

Global Biological Safety Testing Market Competitive Landscape

Biological Safety Testing Market Top Player’s Company Profiles

Charles River Laboratories International, Inc. (United States)

Lonza Group Ltd. (Switzerland)

Merck KGaA (Germany)

SGS SA (Switzerland)

Eurofins Scientific SE (Luxembourg)

Thermo Fisher Scientific Inc. (United States)

WuXi AppTec Co., Ltd. (China)

bioMérieux SA (France)

Nelson Laboratories, LLC (United States)

Avance Biosciences (United States)

Toxikon Corporation (United States)

Pace Analytical Services, LLC (United States)

Microbac Laboratories, Inc. (United States)

Source BioScience plc (United Kingdom)

Creative Bioarray (United States)

TÜV SÜD AG (Germany)

Pacific BioLabs (United States)

Harlan Laboratories Ltd. (United Kingdom)

Eurofins BioPharma Product Testing (Belgium)

ProPharma Group (United States)

Biological Safety Testing Market

FAQs

Biological Safety Testing Market size was valued at USD 3.73 billion in 2021 and is poised to grow from USD 4.20 billion in 2022 to USD 9.57 billion by 2030, at a CAGR of 12.5% during the forecast period (2023-2030).

These participants are engaging in strategic collaborations with various information technology companies to strengthen their market presence by offering customers improved information management solutions. 'Charles River Laboratories International, Inc. (United States)', 'Lonza Group Ltd. (Switzerland)', 'Merck KGaA (Germany)', 'SGS SA (Switzerland)', 'Eurofins Scientific SE (Luxembourg)', 'Thermo Fisher Scientific Inc. (United States)', 'WuXi AppTec Co., Ltd. (China)', 'bioMérieux SA (France)', 'Nelson Laboratories, LLC (United States)', 'Avance Biosciences (United States)', 'Toxikon Corporation (United States)', 'Pace Analytical Services, LLC (United States)', 'Microbac Laboratories, Inc. (United States)', 'Source BioScience plc (United Kingdom)', 'Creative Bioarray (United States)', 'TÜV SÜD AG (Germany)', 'Pacific BioLabs (United States)', 'Harlan Laboratories Ltd. (United Kingdom)', 'Eurofins BioPharma Product Testing (Belgium)', 'ProPharma Group (United States)'

In vitro testing methods, such as cell-based assays and immunoassays, are gaining popularity due to their advantages over traditional animal-based testing. These methods provide quicker results, reduce the need for animal testing, and offer cost-efficiency, thereby driving their adoption and fueling market growth.

Patient safety has emerged as a critical concern in the healthcare industry, leading to a heightened emphasis on rigorous biological safety testing. The occurrence of adverse events due to contaminated or substandard biological products can have severe consequences for patients. As a result, healthcare providers, regulatory authorities, and manufacturers are prioritizing quality control measures to ensure the safety and well-being of patients. This focus on patient safety drives the demand for comprehensive biological safety testing and promotes market growth.

North America dominates the biological safety testing market, accounting for over of the total revenue. The region's dominance can be attributed to several factors, including a well-established healthcare infrastructure, favorable government initiatives, and a large number of pharmaceutical and biotechnology companies. The United States, in particular, plays a pivotal role in driving market growth, owing to substantial investments in research and development activities. The stringent regulatory framework, enforced by agencies such as the Food and Drug Administration (FDA), further emphasizes the need for comprehensive safety testing, boosting market demand.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Global Biological Safety Testing Market Size, Share, Growth Analysis, By Application(Pharmaceutical & Biologics, Cellular & Gene Therapy), By Test(Sterility Tests, Bioburden Tests) - Industry Forecast 2024-2031

Global Biological Safety Testing Market Competitive Landscape

Global Biological Safety Testing Market Report Snapshots

Want to customize this report?

FAQs

Request Free Customization

Feedback From Our Clients

$5,300

Global Biological Safety Testing Market Size, Share, Growth Analysis, By Application(Pharmaceutical & Biologics, Cellular & Gene Therapy), By Test(Sterility Tests, Bioburden Tests) - Industry Forecast 2024-2031

Global Biological Safety Testing Market Competitive Landscape

Global Biological Safety Testing Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Biological Safety Testing Market?

Who are the key vendors in the Global Biological Safety Testing Market?

What is the key driver of Global Biological Safety Testing Market?

What is the key market trend for Global Biological Safety Testing Market?

Which region accounted for the largest share in Global Biological Safety Testing Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300